Recent Articles from Investor Brand Network

According to Dr. Sanjay Gupta, his long-running documentary series “Weed” has grown far beyond its original scope, evolving into an ongoing examination of cannabis, medicine, and patient experience.

American Fusion (OTC: AMFN) announced its inclusion in an editorial published by AINewsWire, highlighting the growing strain AI-driven computing is placing on global energy infrastructure. The feature underscores the company’s positioning in aneutronic fusion and advanced energy systems aimed at supporting the rising power demands of hyperscale data centers and next-generation AI workloads.

American Fusion (OTC: AMFN) reported continued progress in building its intellectual property portfolio around its Texatron(TM) fusion platform, with approximately 280 patent filings in progress and plans to pursue an additional 300 filings covering reactor design, plasma behavior, and system integration. The company also highlighted ongoing regulatory preparations, including its upcoming Q1 2026 Form 10-Q, a potential Frankfurt Stock Exchange dual listing, and continued defense in Delaware litigation, as it positions its technology for commercialization, partnerships, and expanding energy market opportunities.

This article has been disseminated on behalf of Element 29 Resources Inc. and may include paid advertising.

Perpetuals.com (NASDAQ: PDC) announced the expansion of its BayesShield AI technology into healthcare with the launch of BayesShield Clinical, designed to identify physicians with the strongest diagnostic accuracy across specific case types. The platform applies the company’s statistical methodology, originally developed for financial markets, to reduce bias and improve clinical decision-making, with initial deployment supported through a partnership with the European Institute of Management to oversee pilot programs and academic validation.

So far this year, the Bank of Russia has divested gold amounting to about 22 tons in a bid to fund the deficit in its budget. The budget shortfall amounted to approximately $61.3 billion by March’s end due to dwindling revenues from oil and gas.

NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a positive Discipline Review Letter from the FDA Office of Generic Drugs covering quality-related aspects of its ketamine ANDA, with only minor administrative updates requested. The company also reported a supportive meeting with FDA leadership aligned with federal priorities to accelerate treatments for severe mental illness, reinforcing expectations for potential approval of its preservative-free ketamine product in summer 2026.

Nutriband (NASDAQ: NTRB) announced that CEO and Co-Founder Gareth Sheridan appeared on the Jack Neel Podcast to discuss the opioid crisis and the company’s AVERSA(TM) abuse-deterrent transdermal technology. The episode outlines how AVERSA(TM) is designed to reduce misuse, diversion, and accidental exposure of high-risk drugs such as fentanyl, while maintaining patient access, and is supported by a broad global patent portfolio.

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising.

SKYX Platforms (NASDAQ: SKYX) announced an agreement with OTT Heritage Hospitality to deploy and market its smart home and building technologies across European hotel chains and real estate developments. The partnership is expected to support large-scale adoption of SKYX’s technologies across hundreds of hotels and buildings, targeting deployment of hundreds of thousands of units while leveraging time and cost efficiencies of up to 90% for renovations and new builds, as part of the company’s broader global expansion strategy.

Datavault AI (NASDAQ: DVLT) announced the issuance of U.S. Patent No. 12,596,819 along with Notices of Allowance for two additional patent applications, strengthening its position in AI-driven data monetization, tokenization, and digital asset infrastructure. The expanded intellectual property portfolio supports platforms spanning data valuation, virtual asset funding, and automated tax solutions for digital assets, as the company advances commercialization efforts across multiple sectors and targets continued growth in emerging data and real-world asset markets.

BluSky AI (OTCID: BSAI), announced that CEO Trent D’Ambrosio will present at the AI & Tech Virtual Investor Conference hosted by VirtualInvestorConferences.com on April 23, 2026, at 1:30 p.m. ET. The live, interactive event will include real-time Q&A with investors, with additional availability for one-on-one meetings on April 23, 24, 27, and 28, and an archived webcast accessible following the presentation.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.

DitGold (CRYPTO: DITAU) was featured in a BiconomyCom Talks interview discussing its blockchain-based approach to treating data as a core economic asset through decentralized verification, tokenization, and monetization. Built on the Ethereum network, the project’s DitAu token supports governance, staking, and access to data-driven tools, as the company advances a phased roadmap aimed at enabling transparent, community-driven data ownership and infrastructure.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) is emerging as a key example of how scientific progress is increasingly being reflected as measurable financial value across the biotechnology sector, supported by evolving fair-value accounting practices under U.S. GAAP. Operating at the intersection of oncology and AI-driven drug development, the company highlights this shift through its diversified pipeline and strategic holdings, including a 45% stake in GMP Bio valued at over $1 billion, alongside peers such as Autolus Therapeutics plc (NASDAQ: AUTL), Wave Life Sciences Ltd. (NASDAQ: WVE), IO Biotech Inc. (OTC: IOBTQ), and Roche Holding AG (OTC: RHHBY), as the industry transitions toward valuing clinical progress as an asset class.

Nightfood Holdings (OTCQB: NGTF) provided a corporate update outlining continued momentum through its TechForce Robotics subsidiary, including expansion of its U.S. footprint with a focus on East Coast distribution partnerships and ongoing discussions to enter select international markets. The company reported increasing demand for its AI-enhanced robotics solutions, with accelerated deployments, scaling production capacity, and infrastructure enhancements supporting its strategy for long-term growth in hospitality and service sectors.

The United Nations World Food Program (WFP) has introduced a new artificial intelligence program designed to track and monitor hunger risks across the world. The platform, known as HungerMap Live, is expected to change how governments and humanitarian organizations respond to food crises by offering early warnings and real-time data.

A personalized mRNA vaccine has shown signs of meaningfully extending survival in pancreatic cancer patients . Six-year results from a small but closely tracked clinical trial support that conclusion. The findings are being presented at a major oncology conference in San Diego.

AINewsWire Editorial Coverage : Satellite positioning has long served as the invisible backbone of military operations, underpinning everything from guided munitions to autonomous drone navigation, but that confidence is now fracturing. Across active combat theatres, navigation signals are being systematically jammed, spoofed and degraded at scale, turning one of warfare’s most relied-upon tools into one of its most exploitable vulnerabilities. Drones lose orientation, missions fail mid-flight, and entire system architectures collapse in electronically hostile conditions, prompting defense establishments worldwide to urgently seek alternatives capable of signal-free, satellite-independent operation. Into that gap, SPARC AI Inc. (OTC: SPAIF) ( Profile ) has introduced its software-based Overwatch platform, which enables unmanned systems to navigate and acquire targets in GPS-denied environments without any hardware modifications, a faster-to-deploy, more scalable alternative to the hardware-intensive solutions that currently dominate the sector. The company is part of a cohort of innovators, including Draganfly Inc. (NASDAQ: DPRO), AeroVironment Inc . (NASDAQ: AVAV), Kratos Defense & Security Solutions (NASDAQ: KTOS) and Red Cat Holdings Inc. (NASDAQ: RCAT), all operating where drone technology, artificial intelligence and defense capability intersect with a shared emphasis on autonomous and…

BioMedWire Editorial Coverage: The biotechnology industry is experiencing a subtle yet meaningful transformation that is redefining how value is interpreted within a sector long associated with extended development cycles and inherent uncertainty. As therapeutic candidates advance toward commercialization, scientific achievement is no longer viewed purely as an expense tied to research and development but rather as something that can be quantified as a financial asset. This transition is supported by fair-value accounting principles under U.S. GAAP, which enable life sciences companies to incorporate clinical progress, probability of success and expected commercialization timelines into measurable balance sheet value. Companies at the forefront of this shift, including Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ), are actively leveraging this evolving framework. Operating at the intersection of oncology therapeutics and AI-driven drug development, Oncotelic demonstrates how scientific advancement can influence financial positioning. Through a diversified pipeline and strategic holdings, including a 45% interest in GMP Bio, which was recently assessed at more than $1 billion in enterprise value, the company illustrates how innovation can be reflected in tangible economic terms. As the industry increasingly aligns valuation with development progress rather than current revenue, Oncotelic represents a compelling example of science emerging as a recognized asset class. The company is part of a broader group of organizations developing advanced therapies at the genetic and molecular level, including Autolus Therapeutics plc (NASDAQ: AUTL), Wave Life Sciences Ltd. (NASDAQ: WVE), IO Biotech Inc. (NASDAQ: IOBTQ) and…

Olenox Industries (NASDAQ: OLOX) announced it received a delinquency notice from Nasdaq on April 21, 2026, for failing to file its Form 10-K for the year ended Dec. 31, 2025. The company has 60 days, until June 22, 2026, to submit a plan to regain compliance or file the report, with the potential for an extension of up to 180 days, through Oct. 13, 2026, if Nasdaq accepts its plan, as it works to address the deficiency and maintain listing compliance.

SEGG Media (NASDAQ: SEGG, LTRYW) highlighted strong engagement from its subsidiary Quadrant following the April 9 release of a YouTube video featuring Formula 1 drivers Lando Norris and Carlos Sainz Jr., which has generated more than four million views, including one million within the first 24 hours. The campaign, celebrating 100 years of karting, also drove more than 18.5 million social media impressions and 1.92 million engagements, reinforcing Quadrant’s growth strategy focused on premium content, talent-led storytelling, and expanding brand partnerships.

Solowin Holdings (NASDAQ: AXG) reported preliminary, unaudited results for the fiscal year ended March 31, 2026, highlighting revenue growth to between $27 million and $29 million, nearly ten times higher year over year, driven by expansion in digital asset tokenization, stablecoin infrastructure, and AI-powered services. The company reported a net loss of $11 million to $13 million amid continued investment in technology and global expansion, while cash and cash equivalents rose to between $14 million and $16 million, supported by $18 million to $20 million in financing inflows, as it advances its strategy centered on compliant, institutional-grade digital financial infrastructure.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

Beeline Holdings (NASDAQ: BLNE) will host a stakeholder update call on its first-quarter 2026 results on Thursday, May 14, 2026, at 5 p.m. ET. The call will be led by Chief Executive Officer Nick Liuzza and Chief Financial Officer Chris Moe, who are expected to review the company’s performance and provide updates on ongoing initiatives.

A new bipartisan effort in Congress is offering states a way to sidestep an upcoming federal crackdown on hemp-derived THC products, instead of forcing an immediate nationwide ban. The proposal, introduced last week, would let individual states maintain their existing regulatory systems rather than adopt a stricter federal standard scheduled to begin in November.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Dr. Christopher J. Schaber outlines strategies for navigating constrained funding environment

USA Rare Earth (NASDAQ: USAR) entered a definitive agreement to acquire 100% of Serra Verde Group in a transaction valued at approximately $2.8 billion, consisting of $300 million in cash and 126.8 million shares of common stock, with closing expected in the third quarter of 2026 subject to approvals. The acquisition adds the Pela Ema rare earth mine and processing facility in Brazil—currently the only large-scale producer outside Asia capable of supplying all four key magnetic rare earths—positioning the combined company as a fully integrated platform spanning mining through magnet production while strengthening supply chain security and supporting long-term growth.

Solana and the rest of the crypto market has gone through many ups and downs over the last few years. The current volatility and pressures in the market, encouraged by ongoing geopolitical factors, have led to attractive entry prices for those looking to get involved with crypto. Current prices, along with growing concern about the future of the USD and other fiat currencies, provide a unique buy-low opportunity for investors who either missed out on getting in on crypto before, or are looking to increase their investment in the space.

Applied Digital (NASDAQ: APLD) announced that its subsidiary, APLD ComputeCo 2 LLC, priced a $2.15 billion offering of 6.750% senior secured notes due 2031 at an issue price of 98%, with the transaction closing March 10, 2026. The notes were sold in a private offering to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S, with Roth Capital Partners acting as co-manager.

Massimo Group (NASDAQ: MAMO), operating through its Massimo Motor division, today announced continued expansion of its electric vehicle fleet across municipal, commercial and institutional markets, alongside development of its second-generation autonomous patrol golf cart platform. The company is deploying vehicles across site-based environments including public safety, property management, campuses and industrial facilities, reflecting rising demand for durable, cost-efficient solutions for recurring use. In parallel, Massimo is advancing a next-generation platform designed with integrated autonomous patrol capabilities, continuous monitoring and real-time communication functionality, enabling extended operations and direct data transmission to personnel, with potential applications across manufacturing, commercial properties, campuses, parks and logistics sites.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

American Fusion (OTC: AMFN) is featured in AINewsWire editorial coverage examining how surging artificial intelligence adoption is driving unprecedented demand for electricity and reshaping global energy infrastructure priorities. The report underscores that hyperscale data centers and AI workloads are rapidly increasing power consumption, creating bottlenecks in aging grid systems and elevating energy availability as a critical constraint on future AI growth.

Oncotelic Therapeutics (OTCQB: OTLC) was highlighted in a BioMedWire editorial examining how advancing drug pipelines are increasingly being recognized as measurable financial assets under U.S. GAAP, reflecting a broader shift in biotech valuation. The company was noted for leveraging its diversified pipeline and strategic holdings, including a 45% stake in GMP Bio, recently valued at more than $1 billion, as an example of how scientific progress and proximity to commercialization can directly enhance balance sheet value and investor perception.

NanoViricides, Inc. (NYSE American: NNVC) announced that its antiviral drug candidate NV-387 may address the growing global measles outbreak, citing recent case surges including more than 18,000 suspected infections in Bangladesh and rising cases in the United States. The company stated that NV-387 has demonstrated safety in Phase I clinical trials and efficacy in animal models, positioning it as a potential therapeutic complement to vaccination by reducing transmission and treating infected patients, particularly among vulnerable populations, while also noting plans to pursue orphan and rare pediatric disease designations with the FDA.

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

The closure of the Strait of Hormuz, alongside China’s decision to halt exports of sulfuric acid from May 1, is tightening global supplies of a critical chemical used in copper production. The combined effect is placing mounting pressure on both the agricultural and mining industries, which depend heavily on acid-intensive processes.

China has committed to doubling its clean energy supply within the next decade, with a substantial expansion milestone set for 2030. A senior official at the National Development and Reform Commission delivered the announcement on April 17. The statement added long-awaited specificity to a target embedded in the country’s latest five-year plan, which had left the precise definition of what was to be doubled unresolved.

Electric vehicles have broken free of the oil price cycle that governed their previous adoption waves. While earlier sales surges typically collapsed when energy prices fell and the underlying economic case evaporated, the current expansion rests on an entirely different foundation. The self-reinforcing economics of battery manufacturing have completely changed the economics of owning a battery electric vehicle (BEV).

Primary and metastatic central nervous system (CNS) tumors can have extraordinary biological and anatomical complexity, and these tumors can be hard to identify using traditional imaging or histopathology analysis. Molecular analysis has emerged as a major way to identify these tumors and help medical teams plan how best to help those diagnosed with these cancers.

The White House has described a recent meeting with the leader of AI company Anthropic as “constructive and productive,” signaling a possible shift in tone between the federal government and a firm currently locked in a legal dispute with the Defense Department.

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

AINewsWire Editorial Coverage : Artificial intelligence (“AI”) is no longer just a software revolution; it is rapidly becoming an energy story. As AI models grow larger and more complex, the computational power required to train and operate them is driving a surge in electricity demand that is beginning to outpace existing infrastructure. Hyperscale data centers, once viewed as digital backbones, are now emerging as some of the most energy-intensive assets in the global economy. This shift is forcing governments, utilities and private industry to confront a new reality: energy infrastructure, not computing capability, may become the defining constraint of the AI era. Amid this transition, American Fusion(TM) Inc. (OTC: AMFN) ( Profile ) is positioning itself at the intersection of advanced energy and next-generation infrastructure. Through its focus on aneutronic fusion and related supply chain development, the company is working toward scalable, high-efficiency energy systems designed to meet the demands of AI-driven workloads. Its approach reflects a broader shift across the energy sector, from theoretical innovation toward deployable solutions capable of supporting long-term infrastructure needs. American Fusion joins other leading companies operating at the convergence of AI, electricity demand and energy infrastructure, including NVIDIA Corporation (NASDAQ: NVDA), Microsoft Corporation (NASDAQ: MSFT), Amazon.com Inc. (NASDAQ: AMZN) and…

Wearable Devices (NASDAQ: WLDS) a technology growth company specializing in AI-powered touchless sensing wearables, announced a warrant inducement agreement with an existing institutional investor for the immediate exercise of warrants to purchase up to 2,904,499 ordinary shares at $1.73 per share, generating approximately $5.0 million in gross proceeds. The company plans to use the net proceeds for working capital and general corporate purposes. As part of the agreement, the investor will receive new unregistered warrants to purchase up to 5,082,873 shares at an exercise price of $1.51 per share, exercisable immediately and expiring in five years, with closing expected on or about April 21, 2026, subject to customary conditions.

Backers of a proposed medical marijuana measure in Idaho say they have surpassed 100,000 collected signatures and are now racing to meet an April 30 deadline that would place the issue before voters in November.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

Massimo Group (NASDAQ: MAMO) announced the appointment of Quenton Petersen as Chief Executive Officer, effective April 14, 2026, with David Shan transitioning to Executive Chairman while remaining actively involved in the Company’s strategic direction. Petersen, a nine-year veteran of the company, emphasized continued growth across utility vehicles and electric mobility, alongside a disciplined evaluation of opportunities to integrate advanced technologies such as AI-enabled features and expand into applications including facility operations and smart mobility.

Genius Group (NYSE: GNS) announced the closing of its previously disclosed registered direct offering, raising gross proceeds of approximately $8.0 million through the sale of 21,621,621 ordinary shares (or pre-funded warrants in lieu thereof). The offering was conducted under the Company’s effective shelf registration statement, with D. Boral Capital LLC serving as exclusive placement agent, and proceeds are expected to support the Company’s continued growth as an AI-powered education platform.

By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader

Channelchek, a Noble Financial Group platform, highlights a changing investment landscape in 2025, where capital is increasingly rotating toward differentiated growth opportunities beyond crowded sectors. Within this environment, Enhanced Group Inc.—an emerging sports, media, and consumer health company— is pursuing a public market debut through a proposed business combination with A Paradise Acquisition Corp. (NASDAQ: APAD) , positioning itself within a more selective and disciplined SPAC market.

Wearable Devices (NASDAQ: WLDS) announced a planned cooperation and partnership with Meta-Bounds Inc. to integrate its Mudra neural wristband technology with augmented reality hardware, aiming to enable seamless, touchless spatial interaction. The companies intend to showcase early results of the collaboration at Augmented World Expo 2026 in Long Beach, California, with an initial focus on developing wristband-based controls for AR glasses and a longer-term strategy centered on enterprise partnerships and scalable B2B integration.

Oragenics (NYSE American: OGEN) announced that two patients have been enrolled and eight doses administered in its ongoing Phase IIa clinical trial evaluating ONP-002, its lead candidate for the treatment of mild traumatic brain injury (mTBI), or concussion. The trial is underway at Mackay Base Hospital in Queensland, Australia, with additional sites nearing activation, as the company advances a first-in-class intranasal neurosteroid designed to target the underlying biological effects of brain injury, addressing a significant unmet need in a market with no FDA-approved pharmacological treatments.

OptimumBank Holdings (NYSE American: OPHC) announced that Brean Capital, LLC has initiated equity research coverage of the company, with Director of Research Christopher Marinac assigning a Buy rating and an $8 price target. The report, distributed to Brean’s institutional client base, underscores growing recognition of the company’s business model, operating performance and long-term growth strategy, according to Chairman Moishe Gubin, who highlighted the initiation as a key step in expanding investor awareness.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, is advancing its strategy to embed mortgage and title services directly into digital real estate platforms, with a newly announced partnership with Structured Real Estate Group (“SRG”). The agreement, detailed in a company press release, positions Beeline’s technology inside SRG’s AI-driven property ecosystem, allowing users to move from property selection to financing without leaving a single interface ( https://ibn.fm/DEI7p ).

Oncotelic Therapeutics (OTCQB: OTLC) is featured in recent BioMedWire editorial coverage highlighting a fundamental shift in biotechnology, where scientific progress is increasingly recognized as measurable financial value rather than purely as research expenditure. As clinical-stage assets advance toward commercialization, fair-value accounting frameworks under U.S. GAAP are enabling companies to reflect pipeline progress, probability of success and timing of market entry directly on the balance sheet. Within this evolving landscape, Oncotelic exemplifies the trend through its diversified oncology pipeline and strategic holdings, including its 45% stake in GMP Bio, recently measured at an enterprise value exceeding $1 billion, demonstrating how advancing science can materially strengthen financial positioning.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Aditxt (NASDAQ: ADTX) announced its precision oncology subsidiary, Ignite Proteomics, was featured in a peer-reviewed study published in npj Precision Oncology, a Nature journal, evaluating treatment outcomes in metastatic breast cancer patients receiving trastuzumab deruxtecan. The study found that quantitative HER2-related assays, including Ignite’s Reverse Phase Protein Array platform, provided more predictive insight into patient outcomes than traditional immunohistochemistry methods in certain sub-cohorts, highlighting the potential of advanced biomarker approaches to improve treatment selection in oncology.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Lantern Pharma (NASDAQ: LTRN) announced it has scheduled a mid-May 2026 Type C meeting with the U.S. Food and Drug Administration to seek feedback on proposed protocol amendments to its Phase 2 HARMONIC(TM) trial evaluating LP-300 in non-small cell lung cancer. The proposed changes include focusing enrollment on EGFR Exon 21 L858R patients, shifting to a single-arm study design and extending treatment cycles, supported by emerging clinical data showing an 8.3-month median progression-free survival and encouraging response rates in this difficult-to-treat population.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

NRx Pharmaceuticals (NASDAQ: NRXP) welcomed a newly signed Executive Order aimed at accelerating medical treatments for serious mental illness, including expanded access to psychedelic therapies and faster regulatory pathways. The order directs the FDA to issue priority vouchers for qualifying breakthrough therapies and encourages broader use of clinical trial data and real-world evidence, aligning with NRx’s strategy as it advances its NRX-100 drug candidate and seeks regulatory support to address severe depression, PTSD and suicidality.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Most digital communications are secured by encryption built on mathematical problems so hard that conventional computers cannot realistically solve them. That assumption could soon be broken by quantum computers that exploit properties of matter at subatomic scales to perform certain calculations far more efficiently than conventional machines ever could.

Snapchat’s parent company, Snap Inc., has announced a major round of layoffs, cutting about 1,000 jobs, which is around 16 percent of its workforce. The company is also removing hundreds of open job listings as it shifts its focus toward a leaner and more efficient way of operating. This decision reflects a growing trend in the tech industry where companies are turning to artificial intelligence to handle routine tasks that were once done by humans.